Andrew N Stephens
Dr Andrew N. Stephens heads the Ovarian Cancer Biomarker laboratory at the MIMR-PHI Institute of Medical Research. The group is focussed on understanding the biochemistry and molecular biology underlying ovarian tumour formation and progression, and how this knowledge can be applied to improve tumour detection, reduce patient mortality and provide better disease management for patients. The group is currently undertaking both research and translational studies.
Abstracts this author is presenting:
